InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Cantley Lewis Clayton Jr.. Director active across 1 company, notably AGIOS PHARMACEUTICALS INC. Aggregated, 4 disclosures have been recorded. Breakdown: 0 buy · 4 sells. Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations